A. Gottlieb, “Spesolimab Rapidly Improves Quality of Life in Patients with Generalized Pustular Psoriasis, as per Dermatology Life Quality Index Scores: Data from the Effisayil 2 Trial”, J of Skin, vol. 8, no. 4, p. s409, Jul. 2024.